Summary
The relationship between biomarkers of exposure (such as concentrations of toxicants in blood or breath, or metabolites in urine) and toxicant dose for individuals is influenced by many person- and episode-specific factors which contribute to overall variability in biomarker level for a given dose. This variability results in imprecise biological marker-based estimates of dose for individuals. We hypothesize that pharmacokinetic data from stable-isotope (deuterated) analogs can be used with a pharmacokinetic model to account for individual-related sources of variation, leading to more precise methods of dose estimation for individuals. To establish the degree of similarity in the pharmacokinetics of unlabeled (d0-) and fully deuterated (d8-) toluene, 21 men (ages 20–45) inhaled an equal molar mixture for 2 h. Washout kinetics for both compounds were followed for 4 d in alveolar air and blood. Both compounds exhibited three-phase elimination kinetics in both fluids. The third phase was not always definable for d0- toluene because of concurrent uncontrolled environmental exposures. Considering data from only the first two phases, concentrations of d0- and d8-toluene in alveolar air and blood were well correlated for all subjects, even though pharmacokinetic parameters varied among individuals by 5–9 folds. Further experiments are needed to discern whether correlations between d0- and d8-toluene for the third phase are influenced by an isotope effect; present data support use of d8-toluene as a suitable probe for d0-kinetics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ACGIH (1991) Documentation of the Threshold Limit Values and Biological Exposure Indices, Sixth Edition. American Conference of Governmental Industrial Hygienists, Cincinnati
Andersen ME (1981) A physiologically-based pharmacokinetic description of the metabolism of inhaled gases and vapors - analysis at steady state. Toxicol Appl Pharmacol 60:509–526
Andersson R, Carlsson A, Nordqvist MB, Sollenberg J (1983) Urinary excretion of hippuric acid and o-cresol after laboratory exposure of humans to toluene. Int Arch Occup Environ Health 53:101–108
Dills RL, Kent SD, Checkoway H, Kalman DA (1991) Quantification of volatile solvents in blood by static headspace analysis. Talanta 38:365–374
Dumin J, Womersley J (1974) Body fat assessed from total body density and its estimation from skin fold thickness measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77–97
Lauwerys RR (1983) Industrial chemical exposure: Guidelines for biological monitoring. Biomedical Publications, Davis CA
Ling K-HJ, Hanzlik RP (1989) Deuterium isotope effects on toluene metabolism. Product release as a rate-limiting step in Cytochrome P-450 catalysis. Biochem Biophys Res Commun 1 60:844–849
Lameman WA, Bellar TA, Altschuller AP (1968) Aromatic hydrocarbons in the atmosphere of the Los Angeles basin. Environ Sci Technol 2:1017–1020
US EPA (1985) EPA Method 1624 Revision B: Volatile organic compounds by isotope dilution GC/MS. US Environmental Protection Agency, Washington
Wallace LA, Pellizzari ED, Hartwell TD, et al (1986) Total exposure assessment methodology (TEAM) study: personal exposures, indoor-outdoor relationships, and breath levels of volatile organic compounds in New Jersey. Environ Int 12:369–387
Wallen M (1986) Toxicokinetics of toluene in occupationally exposed volunteers. Scand J Work Environ Health 12:588–593
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morgan, M.S., Dills, R.L. & Kalman, D.A. Evaluation of stable isotope-labeled probes in the study of solvent pharmacokinetics in human subjects. Int. Arch Occup Environ Heath 65 (Suppl 1), S139–S142 (1993). https://doi.org/10.1007/BF00381326
Issue Date:
DOI: https://doi.org/10.1007/BF00381326